Ensuring timely antibody delivery in the face of supply chain challenges - contact us for solutions

Goat F(ab')2 Anti-Mouse IgG3, Human ads-FITC

Cat. No.:
1102-02
Goat F(ab')2 Anti-Mouse IgG3-FITC antibody with minimal reactivity to human proteins for use in flow cytometry and immunocytochemistry assays.
$237.00
Size Price (USD) Quantity
0.5 mg $237.00
More Information
Isotype Goat F(ab')2 IgG
Isotype Control Goat F(ab')2 IgG-FITC
Specificity Reacts with the heavy chain of mouse IgG3
Source Pepsin digest of Goat Anti-Mouse IgG3, Human ads (SB Cat. No. 1100)
Cross Adsorption Mouse IgG1, IgG2a, IgG2b, IgM, and IgA; human immunoglobulins and pooled sera; may react with immunoglobulins from other species
Conjugate FITC (Fluorescein)
Buffer Formulation Phosphate buffered saline containing < 0.1% sodium azide
Clonality Polyclonal
Concentration 0.5 mg/mL
Volume 1.0 mL
Recommended Storage 2-8°C; Avoid exposure to light
Applications Quality tested applications for relevant formats include -
ELISA
FLISA
Flow Cytometry 1-17

Other referenced applications for relevant formats include -
Immunocytochemistry 3,18
RRID Number AB_2794591
Gene ID 380795 (Mouse)
Gene ID Symbol Ighg3 (Mouse)
Gene ID Aliases IgG3
UniProt ID P03987 (Mouse)
UniProt Name IGHG3_MOUSE (Mouse)

Certificate of Analysis Lookup

Enter the Catalog Number and Lot Number for the Certificate of Analysis you wish to view


Need help with this product?
or call 800.722.2255
  1. 1. Schrader CE, Edelmann W, Kucherlapati R, Stavnezer J. Reduced isotype switching in splenic B cells from mice deficient in mismatch repair enzymes. J Exp Med. 1999;190:323-30. (FC)
  2. 2. Lovchik JA, Wilder JA, Huffnagle GB, Riblet R, Lyons CR, Lipscomb MF. Ig heavy chain complex-linked genes influence the immune response in a murine cryptococcal infection. J Immunol. 1999;163:3907-13. (FC)
  3. 3. Hanon E, Stinchcombe JC, Saito M, Asquith BE, Taylor GP, Tanaka Y, et al. Fratricide among CD8+ T lymphocytes naturally infected with human T cell lymphotropic virus type I. Immunity. 2000;13:657-64. (FC, ICC)
  4. 4. Luby TM, Schrader CE, Stavnezer J, Selsing E. The μ switch region tandem repeats are important, but not required, for antibody class switch recombination. J Exp Med. 2001;193:159-68. (FC)
  5. 5. Carpenter MK, Rosler ES, Fisk GJ, Brandenberger R, Ares X, Miura T, et al. Properties of four human embryonic stem cell lines maintained in a feeder-free culture system. Dev Dyn. 2004;229:243-58. (FC)
  6. 6. Furukawa Y, Saito M, Matsumoto W, Usuku K, Tanaka Y, Izumo S, et al. Different cytokine production in tax-expressing cells between patients with human T cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis and asymptomatic HTLV-I carriers. J Infect Dis. 2003;187:1116-25. (FC)
  7. 7. Goon PK, Igakura T, Hanon E, Mosley AJ, Barfield A, Barnard AL, et al. Human T cell lymphotropic virus type I (HTLV-I)-specific CD4+ T cells: immunodominance hierarchy and preferential infection with HTLV-I. J Immunol. 2004;172:1735-43. (FC)
  8. 8. Sánchez A, Factor VM, Schroeder IS, Nagy P, Thorgeirsson SS. Activation of NF-κB and STAT3 in rat oval cells during 2-acetylaminofluorene/partial hepatectomy-induced liver regeneration. Hepatology. 2004;39:376-85. (FC)
  9. 9. Hoffman LM, Hall L, Batten JL, Young H, Pardasani D, Baetge EE, et al. X-inactivation status varies in human embryonic stem cell lines. Stem Cells. 2005;23:1468-78. (FC)
  10. 10. Xu C, Rosler E, Jiang J, Lebkowski JS, Gold JD, O'Sullivan C, et al. Basic fibroblast growth factor supports undifferentiated human embryonic stem cell growth without conditioned medium. Stem Cells. 2005;23:315-23 (FC)
  11. 11. Forsyth NR, Musio A, Vezzoni P, Simpson AH, Noble BS, McWhir J. Physiologic oxygen enhances human embryonic stem cell clonal recovery and reduces chromosomal abnormalities. Cloning Stem Cells. 2006;8:16-23. (FC)
  12. 12. Delaleu N, Immervoll H, Cornelius J, Jonsson R. Biomarker profiles in serum and saliva of experimental Sjögren's syndrome: associations with specific autoimmune manifestations. Arthritis Res Ther. 2008;10:R22. (FC)
  13. 13. Guikema JE, Linehan EK, Tsuchimoto D, Nakabeppu Y, Strauss PR, Stavnezer J, et al. APE1- and APE2-dependent DNA breaks in immunoglobulin class switch recombination. J Exp Med. 2007;204:3017-26. (FC)
  14. 14. Guikema JE, Schrader CE, Leus NG, Ucher A, Linehan EK, Werling U, et al. Reassessment of the role of Mut S homolog 5 in Ig class switch recombination shows lack of involvement in cis- and trans-switching. J Immunol. 2008;181:8450-9. (FC)
  15. 15. Delaleu N, Madureira AC, Immervoll H, Jonsson R. Inhibition of experimental Sjögren's syndrome through immunization with HSP60 and its peptide amino acids 437-460. Arthritis Rheum. 2008;58:2318-28. (FC)
  16. 16. Guikema JE, Schrader CE, Brodsky MH, Linehan EK, Richards A, El Falaky N, et al. p53 represses class switch recombination to IgG2a through its antioxidant function. J Immunol. 2010;184:6177-87. (FC)
  17. 17. Schrader CE, Linehan EK, Ucher AJ, Bertocci B, Stavnezer J. DNA polymerases β and λ do not directly affect Ig variable region somatic hypermutation although their absence reduces the frequency of mutations. DNA Repair. 2013;12:1087-93. (FC)
  18. 18. Peng SL, Moslehi J, Craft J. Roles of interferon-γ and interleukin-4 in murine lupus. J Clin Invest. 1997;99:1936-46. (ICC)
See All References